OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Durability of the First Biologic in Patients with Crohn’s Disease: A Nationwide Study from the epi-IIRN
Ohad Atia, C Friss, Gili Focht, et al.
Journal of Crohn s and Colitis (2023) Vol. 18, Iss. 1, pp. 38-46
Closed Access | Times Cited: 8
Ohad Atia, C Friss, Gili Focht, et al.
Journal of Crohn s and Colitis (2023) Vol. 18, Iss. 1, pp. 38-46
Closed Access | Times Cited: 8
Showing 8 citing articles:
Durability of Adalimumab and Infliximab in Children With Crohn’s Disease: A Nationwide Comparison From the epi-IIRN Cohort
Ohad Atia, C Friss, Gili Focht, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. 11, pp. 2097-2104
Closed Access | Times Cited: 6
Ohad Atia, C Friss, Gili Focht, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. 11, pp. 2097-2104
Closed Access | Times Cited: 6
Higher-Dose Infliximab Induction Achieves Better Maintenance Trough Levels in a National Pediatric IBD Cohort—A Retrospective Study
Emily Stenke, Donya Al‐Hassan, Molly Moclair, et al.
Inflammatory Bowel Diseases (2025)
Closed Access
Emily Stenke, Donya Al‐Hassan, Molly Moclair, et al.
Inflammatory Bowel Diseases (2025)
Closed Access
Predictors of Complicated Disease Course in Adults and Children With Crohn’s Disease: A Nationwide Study from the epi-IIRN
Ohad Atia, Rona Lujan, Rachel Buchuk, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. 12, pp. 2370-2379
Closed Access | Times Cited: 4
Ohad Atia, Rona Lujan, Rachel Buchuk, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. 12, pp. 2370-2379
Closed Access | Times Cited: 4
Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRN
Ohad Atia, C Friss, Gili Focht, et al.
Inflammatory Bowel Diseases (2024)
Closed Access | Times Cited: 3
Ohad Atia, C Friss, Gili Focht, et al.
Inflammatory Bowel Diseases (2024)
Closed Access | Times Cited: 3
Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRN
Ohad Atia, Rachel Buchuk, Rona Lujan, et al.
Inflammatory Bowel Diseases (2024)
Closed Access | Times Cited: 3
Ohad Atia, Rachel Buchuk, Rona Lujan, et al.
Inflammatory Bowel Diseases (2024)
Closed Access | Times Cited: 3
Comparison of endoscopic healing and durability between infliximab originator and CT-P13 in pediatric patients with inflammatory bowel disease
Eun Sil Kim, Sujin Choi, Byung‐Ho Choe, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Eun Sil Kim, Sujin Choi, Byung‐Ho Choe, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Advancements in the management of pediatric inflammatory bowel disease
Jonathan O'Donnell, Sonia Thomas, Eric I. Benchimol
Expert Review of Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 1
Jonathan O'Donnell, Sonia Thomas, Eric I. Benchimol
Expert Review of Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 1
Long-Term Durability of Infliximab Maintenance Therapy Incorporating Plant-Based Diet in Inflammatory Bowel Disease
Mitsuro Chiba, Tsuyotoshi Tsuji, Kunio Nakane, et al.
(2024)
Open Access | Times Cited: 1
Mitsuro Chiba, Tsuyotoshi Tsuji, Kunio Nakane, et al.
(2024)
Open Access | Times Cited: 1
